Position: |
Director to Sr. Director of Analytical Excellence |
Department: |
CMC |
Location: |
Remote (PST Zone) with up to 10% domestic and global travel |
Reports To: |
VP, Global Operations Leader |
Position Summary
This position will help shape Angitia’s analytical strategy and lead analytical method development, qualification, and validation across a growing portfolio. Within this scope, they will define and implement phase-appropriate requirements, introduce state-of-the-art tools, and ensure analytical methods are fit for purpose—from early characterization through routine QC testing. The role will require close collaboration with cross-functional teams and CDMO partners to support regulatory submissions and lead root-cause investigations and troubleshooting activities. The ideal candidate brings experience across diverse biologic modalities and demonstrates the ability to lead in both line and matrixed environments. This is a unique opportunity to build a critical function at a growing biotech company and contribute directly to the advancement of novel therapeutics.
Responsibilities
Qualifications
Salary Range: $210,000 to $250,000
About Angitia
Established in June 2018, Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. Angitia is currently studying 3 biologic product candidates in the clinic for the treatment of osteoporosis (Phase 2), osteogenesis imperfecta (OI) (Phase 1), and spinal fusion (Phase 3). Leveraging the team's extensive experience and scientific acumen in novel drug development, Angitia is committed to providing groundbreaking therapies to satisfy key unmet medical needs. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development, and management from both overseas and domestic large multinational companies. The company has built an organization with offices in Westlake Village, CA and Guangzhou, China that is distinguished by world-class scientists with talents that are proficient in the pathophysiology of musculoskeletal diseases. We utilize cutting-edge technologies of genetics and molecular biology to uncover new mechanisms, signal transduction pathways and their interactions combined with computer aided drug design to identify new drug targets, and to discover and develop new biological and small molecule medicines. The company is committed to serving patients in need by carrying out innovative science including internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking talented individuals who are innovative, ambitious, and great team players to join our vibrant group.
Learn more at www.angitiabio.com.
Benefits:
Syska Hennessy Group
Crinetics Pharmaceuticals
Intercom
ZoomInfo
Renmoney